Technology Transfer Tactics will be offering a webinar entitled "Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi" on August 23, 2018 from 1:00 to 2:00 pm (ET).  Patent Docs author Kevin E. Noonan of McDonnell Boehnen Hulbert & Berghoff LLP will address the following topics:

• Technology background
• Legal development
    – Enablement v. written description
    – Noelle v Ledermann
    – Centocor v. Abbott
    – AbbVie v. Janssen
    – Yeda v. Abbott
• Amgen v. Sanofi: the Federal Circuit clarifies written description for antibodies
    – Ariad v. Eli Lilly
• Implications on antibody patent scope
• Effects on licensing
• Alternative antibody embodiments
• Retroactivity
• Strategy going forward
    – Review and revision of pending patents
    – Claim construction
    – How faculty researchers can help
    – Use of third-parties for characterization

The registration fee for the webinar is $197.  Those interested in registering for the webinar, can do so here.